Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study

[News]

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it plans to initiate patient recruitment for a cancer immunotherapy study by year end. The pilot study seeks to demonstrate an improved immune function in cancer patients as a result of the Aethlon Hemopurifier removing tumor-secreted exosomes from the circulatory system.

More... (http://www.news-medical.net/news/20100504/Aethlon-Medical-plans-to-initiate-patient-recruitment-for-cancer-immunotherapy-study.aspx)